Endocrine paraneoplastic syndromes
- Diagnostic approach
Some cancers make hormones. The sodium, calcium, cortisol or sugar problem they cause can be the first sign of the cancer and can kill faster than it.
What it is
Endocrine paraneoplastic syndromes occur when a tumour that is not an endocrine gland secretes a hormone or hormone-like substance. The main ones are SIADH (ADH, mostly from small-cell lung cancer), humoral hypercalcaemia of malignancy (PTH-related protein, mostly from squamous cell carcinomas, kidney and bladder cancer and adult T-cell leukaemia-lymphoma), ectopic ACTH syndrome (small-cell lung cancer, bronchial, thymic and pancreatic NETs, medullary thyroid carcinoma, phaeochromocytoma) and non-islet-cell tumour hypoglycaemia (incompletely processed IGF-2 from large mesenchymal tumours or liver cancer). Others are calcitriol-mediated hypercalcaemia in lymphoma, erythropoietin causing polycythaemia, hCG causing gynaecomastia or hyperthyroidism, GHRH causing acromegaly and FGF23 causing tumour-induced osteomalacia.
What to know
- Small-cell lung cancer causes SIADH and ectopic ACTH; squamous cell lung cancer causes PTHrP hypercalcaemia.
- SIADH is euvolaemic hyponatraemia with low serum osmolality, inappropriately concentrated urine and urine sodium usually above 30 mmol/L, after excluding hypothyroidism and adrenal insufficiency.
- PTHrP is the commonest cause of hypercalcaemia in cancer; PTH is suppressed and phosphate is often low.
- Lymphomas can cause hypercalcaemia by making calcitriol (high 1,25-dihydroxyvitamin D), which responds to glucocorticoids.
- Ectopic ACTH from small-cell cancer develops over weeks: severe low potassium, hypertension, oedema, weakness and high glucose, often without the classic Cushing appearance.
- Bronchial and other carcinoids make ACTH slowly and can mimic Cushing disease; inferior petrosal sinus sampling separates them.
- Non-islet-cell tumour hypoglycaemia: low glucose with low insulin, C-peptide, beta-hydroxybutyrate and IGF-1, and a high IGF-2 to IGF-1 ratio.
- Hypercalcaemia of malignancy usually means advanced disease and a poor prognosis.
Step-by-step approach
- Name the effect: low sodium, high calcium, low potassium with high cortisol, low glucose, high haemoglobin or low phosphate.
- Measure the body's own controlling hormone: PTH; insulin with C-peptide; ACTH; serum and urine osmolality for ADH.
- A suppressed native hormone with a persisting effect suggests a tumour product: measure PTHrP, calcitriol, IGF-2 or look for ectopic ACTH.
- Exclude the look-alikes: diuretics and hypothyroidism for low sodium, primary hyperparathyroidism for high calcium, insulinoma for hypoglycaemia.
- Find the tumour: chest CT first for most; abdominal CT and somatostatin-receptor PET for NETs; whole-body imaging for small mesenchymal tumours.
- Treat the metabolic emergency while staging; then treat the tumour, which is the only lasting cure.
Which tumour makes which hormone, and the lab signature
| Syndrome | Hormone | Typical tumours | Lab signature |
|---|---|---|---|
| SIADH | ADH (vasopressin) | Small-cell lung cancer; head and neck and other cancers | Euvolaemic low sodium, urine osmolality above 100 mOsm/kg, high urine sodium |
| Humoral hypercalcaemia | PTHrP | Squamous cell carcinoma (lung, head and neck, oesophagus, cervix), kidney, bladder, breast, adult T-cell leukaemia-lymphoma | High calcium, suppressed PTH, high PTHrP |
| Calcitriol-mediated hypercalcaemia | 1,25-dihydroxyvitamin D | Hodgkin and non-Hodgkin lymphoma | High calcium, suppressed PTH, high calcitriol |
| Ectopic ACTH | ACTH | Small-cell lung cancer, bronchial and thymic carcinoids, pancreatic NET, medullary thyroid carcinoma, phaeochromocytoma | Very high ACTH and cortisol, low potassium, no suppression with high-dose dexamethasone, no petrosal gradient |
| Non-islet-cell tumour hypoglycaemia | Incompletely processed IGF-2 | Solitary fibrous tumour and other large mesenchymal tumours, hepatocellular carcinoma, GIST | Low glucose with low insulin, C-peptide and IGF-1; high IGF-2 to IGF-1 ratio |
| Others | Erythropoietin; hCG; GHRH; FGF23 | Kidney and liver cancer; germ-cell tumours and choriocarcinoma; pancreatic and bronchial NETs; small mesenchymal tumours | Polycythaemia; gynaecomastia or hyperthyroidism; acromegaly with high GHRH; low phosphate with osteomalacia |
Keys to the differential
- A smoker with hyponatraemia and neither oedema nor dehydration needs chest imaging.
- High calcium with a high or normal PTH is primary hyperparathyroidism even in a patient with cancer; only a suppressed PTH points to the tumour.
- Rapid Cushing syndrome with low potassium and weight loss is ectopic ACTH until proven otherwise; slow, mild cases may be a carcinoid that looks like Cushing disease.
- Hypoglycaemia with a huge abdominal or thoracic mass and suppressed insulin is non-islet-cell tumour hypoglycaemia, not an insulinoma.
- In ectopic ACTH, very high cortisol overwhelms the kidney enzyme that normally inactivates it and acts on mineralocorticoid receptors, causing low potassium and alkalosis.
Next step / Initial management
- Sodium with serum and urine osmolality and urine sodium; calcium with PTH, then PTHrP and calcitriol if PTH is suppressed.
- High cortisol: ACTH, potassium and the Cushing workup; hypoglycaemia: insulin, C-peptide, beta-hydroxybutyrate, IGF-1 and IGF-2 drawn during the low glucose.
- Treat the emergency: fluid restriction and slow correction in SIADH; intravenous fluids and a bisphosphonate or denosumab in hypercalcaemia; steroidogenesis inhibitors for ectopic ACTH; glucose and glucocorticoids for tumour hypoglycaemia.
- Image for the primary tumour, starting with chest CT.
- Refer urgently to oncology and endocrinology; severe hyponatraemia, hypercalcaemia or hypoglycaemia needs hospital care.
Common traps
- High calcium in a cancer patient is always caused by the cancer: primary hyperparathyroidism is common and can coexist, so a normal or high PTH means the parathyroid, not the tumour, is the cause.
- Ectopic ACTH looks like classic Cushing syndrome: in small-cell lung cancer it develops too fast for the classic appearance and shows as low potassium, hypertension, oedema and weakness.
- Hypoglycaemia with a tumour means an insulinoma: large mesenchymal tumours cause hypoglycaemia through IGF-2 with insulin suppressed, so insulin and C-peptide separate the two.
- SIADH can be diagnosed in a patient who is dry or on diuretics: low volume and diuretics also concentrate the urine and raise ADH, so SIADH needs euvolaemia and normal thyroid and adrenal function.
- Fast correction of chronic hyponatraemia is safest: the brain has adapted to the low sodium, and correcting too fast can cause osmotic demyelination, so the daily rise is limited.
Test yourself
Think of the answer, then tap the question to see it.
A 65-year-old smoker has a calcium of 14 mg/dL, a low PTH and a cavitating lung mass. What substance is responsible?
PTH-related protein from a squamous cell lung carcinoma (humoral hypercalcaemia of malignancy); the patient's own PTH is suppressed by the high calcium.
Over six weeks a smoker develops weakness, potassium 2.5 mmol/L, hypertension and oedema; cortisol and ACTH are very high. What is the likely cause?
Ectopic ACTH syndrome from small-cell lung cancer: rapid, severe hypercortisolism with low potassium rather than classic Cushing features.
A man with a large pleural solitary fibrous tumour has fasting hypoglycaemia with low insulin and C-peptide. What causes it?
Non-islet-cell tumour hypoglycaemia: the tumour secretes incompletely processed IGF-2, which activates insulin receptors and suppresses insulin, growth hormone and IGF-1.
Why does hypercalcaemia in a patient with Hodgkin lymphoma respond to glucocorticoids?
The lymphoma makes calcitriol (1,25-dihydroxyvitamin D), which raises gut calcium absorption; glucocorticoids reduce its production by the lymphoma tissue.
Elsewhere in DurgiPedia
Connections
Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.
Sources: Paraneoplastic Syndromes (StatPearls (NCBI Bookshelf), 2023); Malignancy-Related Hypercalcemia (StatPearls (NCBI Bookshelf), 2025); Syndrome of Inappropriate Antidiuretic Hormone Secretion (StatPearls (NCBI Bookshelf), 2023).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
